EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies

Ramesh Kordi iD, Arthur J Chang iD, Mark D Hicar iD

Microorganisms · 10.02.2024 · 12 (2) · 367

DOI: 10.3390/microorganisms12020367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 10.02.2024. Verfasst von Ramesh Kordi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, State University of New York at Buffalo, Buffalo, NY 14203, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wildermuth Memorial Foundation (USA) through Variety, the Children's Charity of Buffalo & Western New York (USA), Wildermuth Memorial Foundation (USA) through Variety, the Children’s Charity of Buffalo & Western New York (USA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coxsackieviruses (CVs) are common causes of infections and can be life-threatening. Unfortunately, rigorous studies guiding the clinician in interpreting CV serum antibody titer testing is lacking. To explore the epidemiology of circulating CVs and the serological test utility in aiding diagnosis of CV infections in our community, we obtained results of CV immunologic diagnostic tests between 2018 and 2022 from a regional healthcare database. For CV type A, rare individuals had positive CF (complement fixation) tests whereas all 16 individuals with IFA testing showed at least one positive serotype. For CV type B CF testing, 52.2% of 222 patients had at least one serotype positive, with B5 being most common and also the most common with higher titers (14.8% with ≥1:32). We found a significant reduction in seropositivity rate during the pandemic in 2020 compared to 2018, which continued through 2022 (OR: 0.2, 95% CI: 0.08–0.49, p-value < 0.001). During the pandemic, the seasonal pattern of positive tests varied from the pre-pandemic pattern. Testing for CVs was increased after the first year of the pandemic. Overall, the variability by month and seasonal change in our data support that CF testing can be used to identify recent CVB infection.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2 pandemiccomplement fixationcoxsackievirus A (CVA)coxsackievirus B (CVB)indirect immunofluorescence assayseroprevalence

Autor:innen und Institutionen

  • Department of Pediatric Infectious Diseases, State University of New York at Buffalo, Buffalo, NY 14203, USA.
  • Division of Pediatric Infectious Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.

ORCID-Profile: Ramesh Kordi, Arthur J Chang, Mark D Hicar

Förderung

  • Wildermuth Memorial Foundation (USA) through Variety, the Children's Charity of Buffalo & Western New York (USA)
  • Wildermuth Memorial Foundation (USA) through Variety, the Children’s Charity of Buffalo &amp; Western New York (USA)

Zitieren

APA

Kordi, R., Chang, A. J., & Hicar, M. D. (2024). Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies. Microorganisms, 12(2), 367. https://doi.org/10.3390/microorganisms12020367

Vancouver

Kordi R, Chang AJ, Hicar MD. Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies. Microorganisms. 2024;12(2):367. doi:10.3390/microorganisms12020367

BibTeX
@article{Kordi2024,
  author = {Kordi, Ramesh and Chang, Arthur J and Hicar, Mark D},
  title = {Seasonal Testing, Results, and Effect of the Pandemic on Coxsackievirus Serum Studies},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {367},
  doi = {10.3390/microorganisms12020367}
}
Kostenlos starten →